American Psychiatric Ass'n v. Anthem Health Plans, Inc.

821 F.3d 352, 61 Employee Benefits Cas. (BNA) 2637, 2016 U.S. App. LEXIS 8797, 2016 WL 2772853
CourtCourt of Appeals for the Second Circuit
DecidedMay 13, 2016
DocketNo. 14-3993-cv
StatusPublished
Cited by234 cases

This text of 821 F.3d 352 (American Psychiatric Ass'n v. Anthem Health Plans, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Psychiatric Ass'n v. Anthem Health Plans, Inc., 821 F.3d 352, 61 Employee Benefits Cas. (BNA) 2637, 2016 U.S. App. LEXIS 8797, 2016 WL 2772853 (2d Cir. 2016).

Opinion

JOHN M. WALKER, JR., Circuit Judge:

Plaintiffs-Appellants are two individual psychiatrists, Susan Savulak, M.D., and Theodore Zanker, M.D. (“the psychiatrists”), and three professional associations of psychiatrists, the American Psychiatric Association, the Connecticut Psychiatric Society, Inc., and the Connecticut Council of Child and Adolescent Psychiatry (collectively, “the associations”). They brought suit in the United States District Court for the District of Connecticut against Defendants-Appellees, four health-insurance companies: Anthem Health Plans, Inc. (doing business as Anthem Blue Cross & Blue Shield of Connecticut); Anthem Insurance Companies, Inc.’ (doing business as Anthem Blue Cross and Blue Shield); Wellpoint, Inc.; and Wellpoint Companies, Inc. (collectively, “the health insurers”). The psychiatrists and the associations allege that the health insurers’ reimbursement practices discriminate against patients with mental health and substance use disorders in violation of the Mental Health Parity and Addition Equity Act of 2008 (“MHPAEA”), Pub.L. No. 110-343, Div. C §§ 511-12, 122 Stat. 3861, 3881, codified at 29 U.S.C. § 1185(a), and the Employee Retirement Income Security Act (“ERISA”), 29 U.S.C. §§ 1001-1461. The associations brought suit on behalf of their members and their members’ patients, while the psychiatrists brought suit on behalf of themselves and their patients. The district court dismissed the case after concluding that the psychiatrists lacked a cause of action under the statute and the associations lacked constitutional standing to pursue their respective claims. We AFFIRM.

[356]*356BACKGROUND

The .psychiatrists and the associations allege that the health insurers discriminate against patients with mental health and substance use disorders by systemically reimbursing providers of services to treat these disorders at a less favorable rate than for other healthcare services. They argue that this less favorable reimbursement policy prevents many psychiatrists from accepting health insurance. The policy limits patients’ access to necessary services and frequently forces them to change providers. Plaintiffs allege that this practice discriminates against patients' with mental health and substance use disorders in violation of the MHPAEA and ERISA.

Congress enacted the MHPAEA to end discrimination in the provision of insurance coverage for mental health and substance use disorders as compared to coverage for medical and surgical conditions in employer-sponsored group health plans. See Coalition for Parity, Inc. v. Sebelius, 709 F.Supp.2d 10, 13 (D.D.C.2010). The MHPAEA expanded the scope of prior legislation, the Mental Health Parity Act of 1996, Pub.L. No. 104-204, §§ 701-02,110 Stat. 2874, 2944.

Under the MHPAEA, if a covered insurer’s “plan or coverage” does not include aggregate lifetime limits “on substantially all medical and surgical benefits, the plan or coverage may not impose any aggregate lifetime limit on mental health or substance use disorder benefits.” 29 U.S.C. § 1185a(a)(l)(A). The same is true with respect to annual limits. Id. § 1185a(a)(2)(A)! .Additionally, if an insurer “provides both medical and surgical benefits and mental health or substance use disorder’ benefits,” the insurer must ensure that both “the financial requirements” and “the treatment limitations” applicable to mental health and substance use disorder benefits “are no more restrictive” than the predominant financial requirements and treatment limitations that apply to medical and surgical benefits; Id. § 1185(a)(3)(A).

Insurers are forbidden, for example, from having either “separate cost sharing requirements that are applicable only with respect to mental health or substance use disorder benefits,” § 1185(a)(3)(A)(i), or “separate treatment limitations that aré applicable only with respect to mental health or substance use disorder benefits,” id. § 1185(a)(3)(A)(ii); see also 26 U.S.C. § 9812(a)(3) (parallel provisions in Internal Revenue Code); 42 U.S.C. § 300gg-5(a) (“A group health plán and a health insurance issuer offering group or individual health insurance coverage shall not discriminate with respect to participation under the plan or coverage against any health care provider who is acting within the scope of that provider’s license or certification under applicable State law.”).

The psychiatrists and the associations, on behalf of their various patients and members (and in the case of Dr. Savulak, as assignee of two of her patients), allege that the health insurer's’ conduct violates the foregoing anti-discrimination provisions of the MHPAEA and breaches .the insurers’ fiduciary duties under § .502(a)(3) of ERISA. The psychiatrists and the associations also allege state-law claims for breach of contract and tortious interference with contract. The complaint seeks a declaration of the -health- insurers’ obligations under, the MHPAEA;' an order enjoining the health insurers from continuing to discriminate against individuals with mental health and substance use disorders; and : damages related to the state-law claims.

The district court (Janet Bond Arterton, J.) dismissed the action. The district court concluded that the psychiatrists lack [357]*357third-party “statutory standing” to bring claims on behalf of their patients. The district court also rejected Dr. Savulak’s distinct assignee-based theory of a cause of action. The district court assumed without deciding that the assignments of ERISA claims made by two patients to Dr. Savulak were not precluded by the anti-assignment provisions of their plans. But the district court concluded that the assignment conveyed legal rights only, and moreover that the complaint did -not plead any. facts suggesting that the assignment was in exchange for medical treatment, as required for a provider to have a cause of action under ERISA. More generally,- the district court held that-’the physician-par tient relationship does not grant third-party standing in this case because the psychiatrists asserted no constitutional .claims on behalf of their patients, and because the statutes at .issue did not broadly confer a private right of action upon providers. Finally, the district court found that the associations lacked constitutional standing because their individual members lacked standing. ’ ' '

Although the district court concluded that the psychiatrists and the associations lacked standing, it went on to address the health insurers’ argument that the psychiatrists and the associations had failed to state a claim. .. t

The district court first rejected the psychiatrists’ and the'associations’’contention that the health insurers were acting as fiduciaries “with respect to a plan” under ERISA § 3(21)(A), 29 U.S.C. § 1002(21)(A).2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
821 F.3d 352, 61 Employee Benefits Cas. (BNA) 2637, 2016 U.S. App. LEXIS 8797, 2016 WL 2772853, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-psychiatric-assn-v-anthem-health-plans-inc-ca2-2016.